Related Experiment Video
Updated: Jul 27, 2025
09:29
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
17.8K
Hope and Hype around Immunotherapy in Triple-Negative Breast Cancer
Flavia Jacobs1,2, Elisa Agostinetto2, Chiara Miggiano1,3
1Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090 Pieve Emanuele, MI, Italy.
Cancers
|June 10, 2023
Summary
Immunotherapy combined with chemotherapy offers new hope for triple-negative breast cancer (TNBC) treatment. Further research is needed to optimize its use and manage side effects for better patient outcomes.
Area of Science:
- Oncology
- Immunology
- Medical Research
Background:
- Triple-negative breast cancer (TNBC) has a poor prognosis and limited targeted treatment options.
- Chemotherapy has been the primary systemic treatment for decades.
- Immunotherapy shows promise in TNBC due to immune biomarkers like PD-L1 expression.
Purpose of the Study:
- To review current immunotherapy strategies for early and advanced TNBC.
- To discuss limitations in clinical research and identify predictive biomarkers.
- To summarize novel immunotherapeutic approaches beyond PD-(L)1 blockade.
Main Methods:
- Literature review of clinical trials and research studies on TNBC immunotherapy.
- Critical analysis of existing evidence and clinical research limitations.
- Synthesis of data on emerging immunotherapeutic strategies.
Main Results:
- Immunotherapy combined with chemotherapy is approved for early and advanced TNBC.
- TNBC heterogeneity and biomarker identification remain challenges.
- Novel immunotherapies beyond PD-(L)1 blockade are under investigation.
Conclusions:
- Immunotherapy represents a significant advancement in TNBC treatment.
- Addressing disease heterogeneity and identifying predictive biomarkers are crucial.
- Exploring novel immunotherapeutic strategies is essential for future progress.
Related Concept Videos
01:27Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:30Cancer Vaccines
435
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
435
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:49Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K